One CRISPR treatment cut “bad” cholesterol in half for a full year

Written and edited by the WorldPing NewsdeskPublished Updated Original reporting: ScienceDaily

What happened

A single dose of an experimental CRISPR therapy cut LDL cholesterol and triglycerides by about half in patients with difficult-to-treat lipid disorders.

The reductions were still present one year later, with the highest dose lowering LDL by 52.

Key facts

  • The reductions were still present one year later, with the highest dose lowering LDL by 52.
  • Reported by ScienceDaily and published Sun, 27 Sep 2026 13:15:21 UTC.

Why it matters

Research findings and mission results set the evidence base that policy, funding and later discoveries build on.

What to watch next

  • Peer review status and replication of the findings
  • Mission milestones and next scheduled attempt
  • Funding or policy decisions that follow

Coverage timeline

When each newsroom published on this story, oldest first — all times UTC.

  1. Scientists say house cats could help unlock better cancer treatments for humans

  2. One CRISPR treatment cut “bad” cholesterol in half for a full year

Sources

The original report was published by ScienceDaily. WorldPing does not claim that reporting — this page summarises and contextualises it.

Read the full report at ScienceDaily

Related WorldPing coverage